Publications by authors named "Xiangjun Hao"

Claim this Profile
A
A bibliometric analysis of immune-related adverse events in cancer patients and a meta-analysis of immune-related adverse events in patients with hepatocellular carcinoma.
Bengang Wang, Xiangjun Hao, Jinshan Yan, Xin Li, Mingfang Zhao

J Transl Int Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases.
Nan Chen, Renxi Wang, Wanlu Zhu, Xiangjun Hao, Jing Wang

PLoS One· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined.
Heming Li, Xiangjun Hao, Tao Han

Hepatobiliary Surg Nutr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming.
Zhangnan Liu, Mengzhen Fan, Junqing Hou, Sijing Pan, Yanxin Xu, Xiangjun Hao

Cell Death Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming.
Zhangnan Liu, Mengzhen Fan, Junqing Hou, Sijing Pan, Yanxin Xu, Xiangjun Hao

Cell Death Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis